Pancreatic Cancer Research

ResearcherTianjin Medical University Cancer Institute and HospitalNo recent work listed

Xin Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-7060-3814; OpenAlex author ID A5103098826. Sources: OpenAlex.

Their work

Papers
4 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
12
Papers, trials and grants by year

2020: 2 papers · 2021: 2 papers

Papers 4

  1. Role of the preoperative circulating tumor DNA KRAS mutation in patients with resectable pancreatic cancer. Co-author DOI 10.2217/pgs-2020-0183↗
  2. LECT 2 Antagonizes FOXM1 Signaling via Inhibiting MET to Retard PDAC Progression. Co-author DOI 10.3389/fcell.2021.661122↗
  3. PD-L1 is a direct target of cancer-FOXP3 in pancreatic ductal adenocarcinoma (PDAC), and combined immunotherapy with antibodies against PD-L1 and CCL5 is effec… First author DOI 10.1038/s41392-020-0144-8↗
  4. Holliday junction recognition protein promotes pancreatic cancer growth and metastasis via modulation of the MDM2/p53 signaling. First author DOI 10.1038/s41419-020-2595-9↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Chenjing Wang · 2 shared papers, 2020–2021 · strength 0.25
  2. Yunshan Wang · 2 shared papers, 2020–2021 · strength 0.25
  3. He Ren · 2 shared papers, 2020–2021 · strength 0.25
  4. Xiaojie Li · 1 shared paper, 2021 · strength 0.15
  5. Yu Xu · 1 shared paper, 2021 · strength 0.15
  6. Shengnan Li · 1 shared paper, 2021 · strength 0.15
  7. Yu J Cao · 1 shared paper, 2021 · strength 0.14
  8. Yu Cao · 1 shared paper, 2020 · strength 0.11
  9. Shengyu Yang · 1 shared paper, 2020 · strength 0.10
  10. Xiuchao Wang · 1 shared paper, 2020 · strength 0.10
  11. Yanhui Yang · 1 shared paper, 2020 · strength 0.10
  12. Jihui Hao · 1 shared paper, 2020 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.